Deficiency Letters in Generic Applications: Common FDA Findings and How to Avoid Them
Discover the most common FDA deficiency letters in generic drug applications (ANDAs). Learn why dissolution, impurities, and DS sameness trigger rejections, and how to avoid costly delays in 2026.